Quote | CNS Pharmaceuticals Inc. (NYSE:CNSP)
Last: | $ |
---|---|
Change Percent: | 0.24% |
Open: | $4.15 |
Close: | $4.11 |
High: | $4.2986 |
Low: | $4.10 |
Volume: | 44,730 |
Last Trade Date Time: | 02/12/2020 04:44:03 pm |
News | CNS Pharmaceuticals Inc. (NYSE:CNSP)
CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be featured in tomorrow’s Virtual Investor Closing Bell Series. According to the announcemen...
Live video webcast with Chief Executive Officer, John Climaco, on Wednesday, June 17 th at 4:00 PM ET HOUSTON, TX / ACCESSWIRE / July 16, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatm...
Message Board Posts | CNS Pharmaceuticals Inc. (NYSE:CNSP)
Subject | By | Source | When |
---|---|---|---|
$CNSP news all the way baby | StockLogistics | investorshub | 05/06/2023 5:40:01 AM |
My bad, still 2 Mill, I was looking | Sun Dance Kid | investorshub | 05/04/2023 11:38:10 PM |
Did the OS just double? Or did E-Trade | Sun Dance Kid | investorshub | 05/04/2023 11:34:30 PM |
NetworkNewsWire: NetworkNewsBreaks CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Retains Analytics Firm, | NetworkNewsWire | investorshangout | 05/03/2023 8:05:01 PM |
Any ideas? | KeepOn | investorshub | 05/03/2023 1:48:41 PM |
News, Short Squeeze, Breakout and More Instantly...
CNS Pharmaceuticals Inc. Company Name:
CNSP Stock Symbol:
NYSE Market:
CNS Pharmaceuticals Inc. Website:
CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be featured in tomorrow’s Virtual Investor Closing Bell Series. According to the announcemen...
Live video webcast with Chief Executive Officer, John Climaco, on Wednesday, June 17 th at 4:00 PM ET HOUSTON, TX / ACCESSWIRE / July 16, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatm...
Glioblastoma multiforme is an aggressive cancer that grows quickly and spreads rapidly, originating as a growth of cells in the spinal cord or the brain. Researchers at the University of Copenhagen may have discovered how this type of cancer, which primarily effects adults, develops resistance ...